ADELFARMA MARKET ACCESS

ADELFARMA MARKET ACCESS was established as a specialized division of Adelfarma S.r.l. to address a clear need in the Italian pharmaceutical and medical device landscape: helping companies navigate the complex, regionally-varied process of gaining product access to local healthcare markets. Based in Palermo, the agency focuses its efforts primarily on Sicily and Calabria, two regions with distinct administrative and therapeutic protocols, while maintaining correspondents in other Italian regions. The division was created by assembling a team of seasoned professionals—RAMs, KAMs, and ISF specialists—who already possessed deep, long-standing relationships with key local decision-makers, including Opinion Leaders, Therapeutic and Ethics Committees, Health Directorates, Hospital Pharmacies, and Administrative Managers.

Specialized Market Access and Commercial Services

ADELFARMA MARKET ACCESS offers a targeted suite of services designed to bridge the gap between pharmaceutical innovation and local patient access. The core of their work revolves around the inclusion of products in regional formularies (PTOR and PTO), which is a critical step for any drug or device seeking reimbursement and prescription in these territories. They also provide ongoing monitoring of hospital sales and supply data, enabling clients to track real-world uptake and identify potential distribution bottlenecks. Another key offering is the integration of products into therapeutic guidelines and protocols, a process that requires both clinical evidence and local advocacy. Additionally, the agency monitors public tenders, which are common mechanisms for hospital procurement in Italy, helping clients anticipate and respond to competitive bids.

• Product inclusion in regional formularies (PTOR and PTO)
• Sales and hospital supply monitoring
• Integration into therapeutic guidelines and clinical protocols
• Public tender monitoring and analysis
• Support for Health Directorates and top-level hospital structures
• Pharmaceutical product evaluation and cost-benefit analysis
• Clinical study comparison and analysis across drug classes

Supporting Health Directorates and Private Clinics

Beyond direct pharmaceutical company support, ADELFARMA MARKET ACCESS also positions itself as a resource for public and private healthcare institutions. The agency can assist Health Directorates, Hospital Pharmacy Services, and private clinics—both accredited and non-accredited—in evaluating pharmaceutical products, developing therapeutic protocols, and conducting cost-benefit analyses. This dual capability—serving both the supply side (pharma companies) and the demand side (healthcare providers)—reflects a practical understanding of how local market access decisions are made. The team’s ability to compare clinical studies across drug classes adds a layer of scientific rigor that is valued by formulary committees and hospital administrators alike.

Who Benefits from ADELFARMA MARKET ACCESS

This agency is best suited for pharmaceutical and medical device companies that need dedicated, on-the-ground support in Southern Italy, particularly in Sicily and Calabria. Their services are most relevant for firms launching innovative products that require local formulary approval, guideline inclusion, or tender participation. It is also a good fit for companies that prefer a lean, experienced team over a large agency, as ADELFARMA MARKET ACCESS operates with a focused group of senior professionals who have direct relationships with key local stakeholders. For organizations seeking to navigate Italy’s decentralized healthcare system with a partner that understands the nuances of regional decision-making, ADELFARMA MARKET ACCESS offers a practical, results-oriented approach.